CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc. (XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, today reported financial results for the third quarter ended September 30, 2019 and provided an update on corporate progress.   “Throughout the third quarter we have continued to execute… Read More..

DUBLIN, Ohio & DARTMOUTH, Nova Scotia--(BUSINESS WIRE)-- Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB), a company focused on the development of precision immunodiagnostics and immunotherapeutics, and IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage biopharmaceutical company pioneering a novel class of immunotherapies, have entered a preclinical research collaboration to explore… Read More..

Zeng is Chairman and CEO of Hualong (Chongqing) Ltd, part of CQNews.Net, the Second Largest Media Company in China AMSTERDAM, The Netherlands, Nov. 06, 2019 (GLOBE NEWSWIRE) -- Natur International Corp., (NTRU), a “farm-to-functional” producer of natural and organic plant-based foods and beverages, beauty products, and animal care including full… Read More..